E20 CMAJ, January 11, 2011, 183(1) © 2011 Canadian Medical Association or its licensors The barefoot running trend has taken off in recent years, but in some environments running year-round without shoes is simply not an option. Barefoot enthusiasts who live in these places — where winters are extremely cold, or the terrain is too rough, or the sun gets hot enough in summer to turn sidewalks in...

One hundred patients wih rheumatoid arthritis were questioned about the acceptability of the surgical shoes that they had been prescribed for their foot problems. The approach was made from the records of a surgical supplies manufacturer. While 90 per cent experienced good alleviation of symptoms, 50 per cent had complaints regarding fit, comfort and styling. The implications of changes in the ...

13 strains of bacteria were isolated from 12 shoes that were worn by children aged 6 to 12 for more than half a year. Through morphological observation, physiological and biochemical measurements, as well as 16SrRNA sequence analysis, the bacteria were identified as follows: Bacillus licheniformis, Bacillus subtilis (5 subspecies), Bacillus spore (3 subspecies), Bacillus anthracis, Staphylococc...

objective(s): the effect of silica nanoparticles (snps) in sport shoes outsoles on the  parameters related to anterior cruciate ligament (acl) injury has not been investigated. the aim of this study was to investigate the effect of shoes outsole containing a composite of thermoplastic elastomer based on styrene-butadiene and silica nanoparticles (tpen shoe) on knee valgus angle (kva) as a risk ...

BACKGROUND Complex foot and ankle fractures, such as calcaneum fractures or Lisfranc dislocations, are often associated with a poor outcome, especially in terms of gait capacity. Indeed, degenerative changes often lead to chronic pain and chronic functional limitations. Prescription footwear represents an important therapeutic tool during the rehabilitation process. Local Dynamic Stability (LDS...

I n 2012, the estimated incremental burden of diabetic foot ulceration in all Medicare and non-Medicare patients in the United States was $9.1– 13 billion (1). These costs do not include the suffering of patients and families, loss of income, loss of mobility , and predicted increased mortality. Coverage for extra-depth or custom molded therapeutic shoes and inserts for individuals with diabete...